Increased levels of α-1-antichymotrypsin in brains of patients with Alzheimer's disease correlate with activated astrocytes and are affected by APOE 4 genotype

Journal of Neuroimmunology

Volumn 88, Issue 1-2, 1998, Pages 105-110

  Licastro, Federico ^a,b   Mallory, Margareth ^b   Hansen, Lawrence A ^b   Masliah, Eliezer ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF SAN DIEGO   (United States)

Author keywords

ACT; Alzheimer's brain; APOE and oxidative damage; Astroglia

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; APOLIPOPROTEIN E; CD45 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN;

ALLELE; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; BRAIN HOMOGENATE; CONTROLLED STUDY; GENOTYPE; GLIOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROGLIA; NERVE DEGENERATION; OXIDATIVE STRESS; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALPHA 1-ANTICHYMOTRYPSIN; ALZHEIMER DISEASE; ANTIGENS, CD45; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; ASTROCYTES; BRAIN; CELL AGGREGATION; COLORING AGENTS; FEMALE; GENOTYPE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PHENOTYPE; REGRESSION ANALYSIS;

EID: 0032146242     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00096-4     Document Type: Article

References (39)

1. Abraham, C., 1992. The role of the acute-phase protein α-1-antichymotrypsin in brain dysfunction and injury. Res. Immunol. 143, 631-636.
2. Abraham, C.R., Selkoe, D.J., Potter, H., 1988. Immunochemical identification of the serine protease inhibitor, α-1-antichymotrypsin in the brain amyloid deposits. Cell 52, 487-501.
3. Abraham, C.R., Shirahama, T., Potter, H., 1990. α-1-Antichymotrypsin is associated solely with amyloid deposits containing the β-protein. Amyloid and cell localization of α-1-antichymotrypsin. Neurobiol. Aging 11, 123-129.
4. Barger, S.W., Harmon, A.D., 1997. Microglia activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388, 878-881.
5. Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L., Pericak-Vance, M.A., 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923.
6. Eriksson, S., Janciauskiene, S., Lannfelt, L., 1995. α-1-Antichymotrypsin regulates Alzheimer β-amyloid peptide fibril formation. Proc. Natl. Acad. Sci. U.S.A. 92, 2313-2317.
7. Fraser, P.E., Nguyen, J.T., McLachlan, D.R., Abraham, C.R., Kirschner, D.A., 1993. α-1-antichymotrypsin binding to Alzheimer Aβ peptides is sequence specific and induces fibril disaggregation in vitro. J. Neurochem. 6, 298-305.
8. Galasko, D., Saitoth, T., Xia, Y., Thal, L., Katzman, R., Hill, L., Hansen, L., 1994. The apolipoprotein E allele 4 is overexpressed in patients with the Lewy body variant of Alzheimer's disease. Neurology 44, 1950-1951.
9. Gurwitz, D., Cunningham, D.D., 1988. Thrombin modulates and reverses neuroblastoma neurite outgrowth. Proc. Natl. Acad. Sci. U.S.A. 85, 3440-3444.
10. Hansen, L.A., Armstrong, D.M., Terry, R.D., 1987. An immunochemical quantification of fibrous astrocytes in the aging human cerebral cortex. Neurobiol. Aging 8, 1-6.
11. Hansen, L.A., Masliah, E., Galasko, D., Terry, R.D., 1993. Plaque-only Alzheimer disease is usually the Lewy body variant, and vice versa. J. Neuropathol. Exp. Neurol. 52, 648-654.
12. Itagaki, S., McGeer, P.L., Akiyama, H., Zhu, S., Selkoe, D., 1989. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer's disease. J. Neuroimmunol. 24, 173-182.
13. Kilpatrick, L., McCawley, L., Nachiappan, V., Greer, W., Majumdar, S., Kochak, H.E., Douglas, S.D., 1992. α-1-Antichymotrypsin inhibits the NADPH oxidase-enzyme complex in phorbol ester-stimulated neutrophil membranes. J. Immunol. 149, 3059-3065.
14. Koo, E.H., Abraham, C.R., Potter, H., Cork, L.C., Price, D.L., 1991. Developmental expression of α-1-antichymotrypsin in brain may be related to astrogliosis. Neurobiol. Aging 12, 495-501.
15. Licastro, F., Morini, M.C., Davis, L.J., Malpassi, P., Cucinotta, D., Parente, R., Melotti, C., Savorani, G., 1994. Increased chemiluminescence response of neutrophils from the peripheral blood of patients with senile dementia of Alzheimer's type. J. Neuroimmunol. 51, 21-26.
16. Liu, X., Erikson, C., Brun, A., 1996. Cortical synaptic changes and gliosis in normal aging, Alzheimer's disease and frontal lobe degeneration. Dementia 7, 128-134.
17. Lowry, O.H., Rosenburg, N.J., Farr, A.L., Randall, R.J., 1951. Protein measurement with the pholin phenol agent. J. Biol. Chem. 193, 265-275.
18. Ma, J., Yee, A., Brewer, H.B., Das, S., Potter, H., 1994. Amyloid-associated proteins α-1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372, 92-94.
19. Mancardi, G.L., Liwnicz, B.H., Mandybur, T.I., 1983. Fibrous astrocytes in Alzheimer's disease and senile dementia of Alzheimer's type. Acta Neuropathol. 61, 76-84.
20. Masliah E., Licastro F., 1997. Neuronal and synaptic loss, reactive gliosis, microglia response and induction of complement cascade. In: Clark, C., Trojanowski, J.O., (Eds.), Neurodegenerative Dementia, Clinical Features and Pathological Mechanisms. McGaw-Hill, New York (in press).
21. Masliah, E., Miller, A., Terry, R.D., 1993. The synaptic organization of the neocortex in Alzheimer's disease. Med. Hypoth. 41, 334-340.
22. Masters, C.L., Simms, G., Weinmann, N.A., Multhaup, G., McDonald, B.L., Beyreuther, K., 1985. Amyloid plaque core protein in Alzheimer's disease and Down's syndrome. Proc. Natl. Acad. Sci. U.S.A. 82, 4245-4249.
23. Meda, L., Cassatella, M.A., Szendrei, G.I., Otvos, L., Baron, P.L., Villaba, M., Ferrari, D., Rossi, F., 1995. Activation of microglia cells by β-amyloid protein and interferon-γ. Nature 374, 647-649.
24. Mrak, R.E., Sheng, J.G., Griffin, S.T., 1995. Glial cytokines in Alzheimer's disease: Review and pathogenetic implications. Hum. Pathol. 26, 816-823.
25. Nixon, R.A., Cataldo, A.M., 1994. Free radicals, proteolysis and degeneration of neurons in Alzheimer's disease: how essential is the β-amyloid link?. Neurobiol. Aging 15, 463-469.
26. Pasternack, J.M., Abraham, C.R., Van Dyke, B.J., Potter, H., Younkin, S.G., 1989. Astrocytes in Alzheimer's disease gray matter express α-1-antichymotrypsin mRNA. Am. J. Pathol. 135, 827-834.
27. Patterson, P.H., 1995. Cytokines in Alzheimer's disease and multiple sclerosis. Curr. Opinion Neurobiol. 5, 642-646.
28. Perraud, F., Besnard, F., Labourdet, G., Sensenbrenner, M., 1988. Proliferation of rat astrocytes but not of oligodendrocytes is stimulated in vitro by protease inhibitors. Int. J. Dev. Neurosci. 6, 261-266.
29. Rogers, J., Cooper, N.R., Webster, S., Schulzt, J., McGeer, P.L., Styren, S.D., Civin, W.H., Brachova, L., Bradt, B., Ward, P., Lieberburg, I., 1992. Complement activation by β-amyloid in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 89, 10016-10020.
30. Rogers, J., Webster, S., Lue, L.F., Brachova, L., Civin, W.H., Emmerling, M., Shivers, B., Walker, D., McGeer, P., 1996. Inflammation and Alzheimer's disease pathogenesis. Neurobiol. Aging 17, 681-686.
31. Saitoh, T., Kang, D., Mallory, M., DeTeresa, R., Masliah, E., 1997. Glial cells in Alzheimer's disease: preferential effect of APOE risk on scattered microglia. Gerontology 43, 109-118.
32. Salinero, O., Moreno-Flores, M.T., Ceballos, M.L., Wandosell, F., 1997. β-Amyloid peptide induced cytoskeletal reorganization in cultured astrocytes. J. Neurosci. Res. 47, 216-223.
33. Schechter, R., Yen, S.H.C., Terry, R.D., 1981. Fibrous astrocytes in senile dementia of Alzheimer type. J. Neuropathol. Exp. Neurol. 40, 95-101.
34. Schuster, M.G., Enriquez, P.M., Curran, P., Cooperman, B.S., Rubin, H., 1992. Regulation of neutrophil superoxide by antichymotrypsin-chymotrypsin complexes. J. Biol. Chem. 267, 5056-5059.
35. Schmechel, D.E., Saunders, A.M., Strittmatter, W.J., Crain, B.J., Hulette, C.M., Joo, S.H., Pericak-Vance, M.A., Goldgaber, D., Roses, A.D., 1993. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 90, 9649-9653.
36. Terry, R.D., Peck, A., DeTeresa, R., Schechter, R., Horoupian, D.S., 1981. Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann. Neurol. 10, 184-192.
37. Tooyama, I., Kimura, H., Akiyama, H., McGeer, P.L., 1990. Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease. Brain Res. 523, 273-280.
38. Travis, J., Salvelsen, G.S., 1983. Human plasma proteinase inhibitors. Annu. Rev. Biochem. 52, 655-709.
39. Weisgraber, K.H., Mahley, R.W., 1996. Human apolipoprotein E: the Alzheimer's disease connection. FASEB J. 10, 1485-1494.